statistiche ricercatore

SPANEVELLO, ANTONIO

Distribuzione geografica

Continente	#
NA - Nord America	16.238
EU - Europa	8.758
AS - Asia	2.203
OC - Oceania	37
SA - Sud America	34
AF - Africa	18
Continente sconosciuto - Info sul continente non disponibili	11
Totale	27.299

Salva come PNG Salva come JPEG

Nazione	#
US - Stati Uniti d'America	16.196
IT - Italia	4.687
UA - Ucraina	1.541
CN - Cina	855
TR - Turchia	653
SE - Svezia	630
VN - Vietnam	552
IE - Irlanda	545
GB - Regno Unito	410
FI - Finlandia	346
DE - Germania	306
FR - Francia	70
NL - Olanda	58
CA - Canada	36
IN - India	33
AU - Australia	28
JP - Giappone	23
AT - Austria	22
BE - Belgio	22
CZ - Repubblica Ceca	20
RU - Federazione Russa	20
KR - Corea	18
BR - Brasile	17
SG - Singapore	16
ES - Italia	11
EU - Europa	11
PL - Polonia	11
CH - Svizzera	10
NZ - Nuova Zelanda	9
RO - Romania	9
CL - Cile	7
HK - Hong Kong	7
PE - Perù	7
IR - Iran	6
MY - Malesia	6
NO - Norvegia	6
TW - Taiwan	6
GR - Grecia	5
MA - Marocco	5
MX - Messico	5
NG - Nigeria	5
AE - Emirati Arabi Uniti	4
HU - Ungheria	4
KZ - Kazakistan	4
MD - Moldavia	4
SA - Arabia Saudita	4
AR - Argentina	3
BG - Bulgaria	3
DK - Danimarca	3
DZ - Algeria	3
LK - Sri Lanka	3
MM - Myanmar	3
PT - Portogallo	3
AL - Albania	2
BA - Bosnia-Erzegovina	2
HR - Croazia	2
ID - Indonesia	2
SK - Slovacchia (Repubblica Slovacca)	2
ZA - Sudafrica	2
BD - Bangladesh	1
EG - Egitto	1
GH - Ghana	1
IL - Israele	1
JO - Giordania	1
KH - Cambogia	1
LT - Lituania	1
LU - Lussemburgo	1
LV - Lettonia	1
MO - Macao, regione amministrativa speciale della Cina	1
MZ - Mozambico	1
PA - Panama	1
PK - Pakistan	1
SI - Slovenia	1
SY - Repubblica araba siriana	1
TH - Thailandia	1
Totale	27.299

Salva come PNG Salva come JPEG

Città	#
Milan	3.378
Fairfield	2.338
Woodbridge	1.831
Jacksonville	1.255
Houston	1.208
Ann Arbor	1.207
Ashburn	1.193
Chandler	1.100
Wilmington	923
Seattle	918
Cambridge	787
Princeton	532
Dublin	527
Shenzhen	435
Dearborn	410
Izmir	372
Nyköping	314
Dong Ket	285
Rome	267
San Diego	166
Como	126
New York	121
San Mateo	120
Ogden	104
London	71
Dallas	70
Hefei	69
Boardman	68
Washington	64
Beijing	63
Falls Church	57
Kocaeli	49
Nanjing	42
Kunming	38
Norwalk	36
Helsinki	35
San Genesio Ed Uniti	32
Los Angeles	30
Verona	27
Düsseldorf	23
Redmond	23
Amsterdam	22
Jinan	22
Redwood City	22
Toronto	22
Vienna	21
Brussels	20
Guangzhou	19
San Francisco	19
Tokyo	19
Magnago	18
Kilburn	17
Phoenix	17
Brno	16
Philadelphia	16
Munich	15
Pavia	15
Chicago	14
Indiana	14
Chiswick	13
New Bedfont	13
Chennai	12
Nanchang	12
Prescot	12
Chengdu	11
São Paulo	11
Hangzhou	10
Shenyang	10
Baotou	9
Lappeenranta	9
Naples	9
Edinburgh	8
Fuzhou	8
Melbourne	8
Montreal	8
Pune	8
Singapore	8
Southwark	8
Acton	7
Meppel	7
Warsaw	7
Zhengzhou	7
Auburn Hills	6
Brisbane	6
Chongqing	6
Florence	6
Hebei	6
Hounslow	6
Kuala Lumpur	6
Lima	6
Menlo Park	6
Oslo	6
Changsha	5
Fayetteville	5
Islington	5
Manchester	5
Southampton	5
Tappahannock	5
Torino	5
Varese	5
Totale	21.357

Salva come PNG Salva come JPEG

Nome	#
Convergent sets of data from in vivo and in vitro methods point to an active role of Hsp60 in chronic obstructive pulmonary disease pathogenesis	546
The effects of a cognitive behavioural intervention in asthmatic patients.	194
Six-Minute Walking Distance Improvement after Pulmonary Rehabilitation Is Associated with Baseline Lung Function in Complex COPD Patients: A Retrospective Study	185
Airway inflammation in patients affected by obstructive sleep apnea	179
Classifying new anti-tuberculosis drugs: rationale and future perspectives	178
Five-year survival of stage IIIA-IIIB (non-N3) non-small cell lung cancer patients after platinum/gemcitabine induction chemotherapy and surgery.	176
A retrospective TBNET assessment of linezolid safety, tolerability and efficacy in multidrug-resistant tuberculosis	173
Clinical and operational value of the extensively drug-resistant tuberculosis definition.	167
Exhaled pH, exhaled nitric oxide, and induced sputum cellularity in obese patients with obstructive sleep apnea syndrome	167
A European Respiratory Society technical standard: exhaled biomarkers in lung disease	167
Extensively drug-resistant tuberculosis is worse than multidrug-resistant tuberculosis: different methodology and settings, same results.	164
History of tuberculosis and drug resistance	163
Frequent coexistence of chronic heart failure and chronic obstructive pulmonary disease in respiratory and cardiac outpatients: Evidence from SUSPIRIUM, a multicentre Italian survey	162
Resistance to second-line injectables and treatment outcomes in multidrug-resistant and extensively drug-resistant tuberculosis cases.	161
Roflumilast in symptomatic chronic obstructive pulmonary disease: two randomised clinical trials	161
When kidneys and lungs suffer together	160
Exhaled NO and iNOS expression in sputum cells of healthy, obese and OSA subjects	159
Adherence to Continuous Positive Airway Pressure in patients with Obstructive Sleep Apnoea. A ten year real life study	159
Bronchoalveolar lavage causes decrease in PaO2, increase in (A-a) gradient value and bronchoconstriction in asthmatics.	158
Pulmonary rehabilitation is effective in patients with tuberculosis pulmonary sequelae	158
Tuberculosis elimination: theory and practice in Europe	157
Bronchial hyperresponsiveness, airway inflammation, and reversibility in patients with chronic obstructive pulmonary disease	157
Economic analysis of two structured treatment and teaching programs on asthma.	155
A pilot study of nurse-led, home monitoring for patients with chronic respiratory failure and with mechanical ventilation assistance.	154
Microsatellite alterations suggestive of organ-specific asthma and atopy in exhaled breath condensate.	154
Antibiotic treatment of severe exacerbations of chronic obstructive pulmonary disease with procalcitonin: A randomized noninferiority trial	154
Efficacy of pulmonary rehabilitation in chronic respiratory failure (CRF) due to chronic obstructive pulmonary disease (COPD): The Maugeri Study.	153
Improving the TB case management: The International Standards for Tuberculosis Care.	153
Aging and airway inflammation	153
Th2 cytokines impair innate immune responses to rhinovirus in respiratory epithelial cells	153
In vitro susceptibility testing and totally drug-resistant tuberculosis	151
Models of respiratory infections: Virus-induced asthma exacerbations and beyond	151
3p microsatellite signature in exhaled breath condensate and tumor tissue of patients with lung cancer.	150
Therapeutic drug monitoring: How to improve drug dosage and patient safety in tuberculosis treatment	150
Effectiveness and safety of meropenem/ clavulanate-containing regimens in the treatment of MDR- and XDR-TB	150
Estimation of minimal clinically important difference in EQ-5D visual analog scale score after pulmonary rehabilitation in subjects with COPD	150
Prognostic value of Exhaled Microsatellite alterations at 3p in NSCLC patients.	149
Methods of sputum processing for cell counts, immunocytochemistry and in situ hybridisation.	149
Induced sputum to assess airway inflammation: a study of reproducibility.	149
Comparison of effectiveness and safety of imipenem/clavulanate-versus meropenem/clavulanate-containing regimens in the treatment of MDR- and XDR-TB	149
Effects of intradermal injection of atrial natriuretic peptide.	148
Heterogeneity of pulmonary rehabilitation: like apples and oranges - both healthy fruit	148
Tiotropium and exercise training in COPD patients: effects on dyspnea and exercise tolerance.	147
Bronchoalveolar lavage, sputum and exhaled clinically relevant inflammatory markers: values in healthy adults.	146
Inflammation, oxidative stress and systemic effects in mild chronic obstructive pulmonary disease.	146
Fluoroquinolones: are they essential to treat multidrug-resistant tuberculosis?	146
Exhaled matrix metalloproteinase-9 (MMP-9) in different biological phenotypes of asthma	146
Menopausal asthma: a new biological phenotype?	144
Epidemiology and clinical management of XDR-TB: a systematic review by TBNET.	144
Ripped from the headlines: how can we harness communications to control TB?	142
A new Editorial Board of Monaldi Archives for Chest Disease	142
Airway responsiveness to methacholine: effects of deep inhalations and airway inflammation.	142
Prevalence and prevention of venous thromboembolism in patients with acute exacerbations of COPD	142
Recent developments in the diagnosis and management of tuberculosis	142
An electronic nose in the discrimination of patients with asthma and controls.	141
Fibre types in skeletal muscles of chronic obstructive pulmonary disease patients related to respiratory function and exercise tolerance.	141
Airway inflammatory phenotypes: Making sputum cell evaluation more accessible for clinical use	141
Towards a practical clinical use of fractioned exhaled nitric oxide levels in chronic cough	141
Induced sputum in children: feasibility, repeatability, and relation of findings to asthma severity.	140
An electronic nose in the discrimination of patients with non-small cell lung cancer and COPD.	140
Systemic and airway inflammation in sleep apnea and obesity: the role of ICAM-1 and IL-8.	140
Validity and reproducibility of morphologic analysis of nasal secretions obtained using ultrasonic nebulization of hypertonic solution.	140
Consensus not yet reached on key drugs for extensively drug-resistant tuberculosis treatment.	139
Comparison of two methods of processing induced sputum: selected versus entire sputum.	138
SPUTUM AND EXHALED BREATH ANALYSIS	136
Regular versus as-needed budesonide and formoterol combination treatment for moderate asthma: A non-inferiority, randomised, double-blind clinical trial	136
Chronic bronchial asthma from challenge to treatment: epidemiology and social impact.	135
Airways diseases: asthma, COPD and chronic cough highlights from the European Respiratory Society Annual Congress 2018	135
MDR-TB and XDR-TB: drug resistance and treatment outcomes.	134
Do blood eosinophils strictly reflect airway inflammation in COPD? Comparison with asthmatic patients	134
Inhaled corticosteroids reduce neutrophilic bronchial inflammation in patients with chronic obstructive pulmonary disease.	134
Effect of methacholine challenge on cellular composition of sputum induction.	133
Efficacy, safety and tolerability of linezolid containing regimens in treating MDR-TB and XDR-TB: systematic review and meta-analysis.	133
Airway inflammation in patients affected by obstructive sleep apnea syndrome.	133
Effects of Pulmonary Rehabilitation in Patients with Non-Cystic Fibrosis Bronchiectasis: A Retrospective Analysis of Clinical and Functional Predictors of Efficacy	132
Integrated care of chronic degenerative non-communicable diseases and rehabilitation: the odd couple?	132
Latex allergy and sensitization in cities: a survey in a population at risk	132
Exhaled inflammatory markers in aspirin-induced asthma syndrome.	132
Aging and induced-sputum cells.	131
Dissociation between airway inflammation and airway hyperresponsiveness in allergic asthma.	131
Development of a Barthel Index based on dyspnea for patients with respiratory diseases	131
Small airway dysfunction and flow and volume bronchodilator responsiveness in patients with chronic obstructive pulmonary disease	131
Is bronchodilator the correct treatment for COPD subjects before EBUS?	131
Airway inflammation in healthy smokers.	130
Predictors of non-invasive ventilation tolerance in amyotrophic lateral sclerosis.	129
Drug resistance beyond extensively drug-resistant tuberculosis: individual patient data meta-analysis	128
Management of drug resistantTB in patients with HIV co-infection	128
Inhalation therapy in the next decade: Determinants of adherence to treatment in asthma and COPD	128
Brittle Asthma	127
Eosinophilia in asthma: The easy way is not always the best	127
Sputum induced cellularity in a group of traffic policemen.	126
Italian survey on prevalence and disease management of chronic heart failure and chronic obstructive pulmonary disease comorbidity in ambulatory patients. SUSPIRIUM study rationale and design	126
Tuberculosis elimination: Where are we now?	126
Genotyping of microsatellite alterations and EGFR somatic mutations in exhaled breath condensate of NSCLC patients	125
Tele-assistance in Chronic Respiratory Failure Patients: a Randomised Clinical Trial.	125
The role of the bronchial microvasculature in the airway remodelling in asthma and COPD	125
Comment on: Daily 300 mg dose of linezolid for the treatment of intractable multidrug-resistant and extensively drug-resistant tuberculosis.	124
WHO strategies for the programmatic management of drug-resistant tuberculosis	124
Attenuation of induced bronchoconstriction in healthy subjects: effects of breathing depth.	123
Airways oxidative stress, lung function and cognitive impairment in aging.	123
Totale	14.874

Salva come PNG Salva come JPEG

Categoria	#
all - tutte	110.940
article - articoli	0
book - libri	0
conference - conferenze	0
curatela - curatele	0
other - altro	0
patent - brevetti	0
selected - selezionate	0
volume - volumi	0
Totale	110.940

Salva come PNG Salva come JPEG

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2019/2020	4.861	0	208	272	1.008	327	551	750	608	389	332	101	315
2020/2021	4.355	119	355	210	385	275	413	196	373	635	283	418	693
2021/2022	2.742	315	328	168	70	83	185	204	176	157	486	221	349
2022/2023	3.395	441	147	291	360	225	701	39	366	452	148	121	104
2023/2024	6.222	840	865	1.323	1.037	1.175	404	101	117	185	94	51	30
2024/2025	139	53	86	0	0	0	0	0	0	0	0	0	0
Totale													27.941